Condition: Treatment Side Effects · Colorectal Cancer · Sponsor: Norwegian Department of Health and Social Affairs
Randomized head-to-head comparison trial among patients who have undergone incomplete endoscopic resection of early colon cancer to evaluate the benefits, harms and burdens, as well as the ecological footprint and cost-effectiveness of endoscopic full thickness resection (eFTR), a minimally invasive endoscopic treatment with a colonoscope, as compared to standard-of-care surgery. Co-primary endpoints are * Rate of severe adverse events classified as grade III to V according to the Clavien Dindo classification within 30-days after study treatment * CRC recurrence or sign of lymph nodes or distant metastases at 3 years after randomization comparing the two treatment groups (eFTR versus surgery).
This description comes directly from the study's public registry record.
Nastazja Pilonis, MD PhD · +48787863649 · nastazja@gmail.com
Michael Bretthauer, MD PhD · +4790132480 · michael.bretthauer@medisin.uio.no
Always discuss trial participation with your own doctor first.
| Vestre Viken Hospital | Oslo, Akershus, Norway | Recruiting |
| Akershus University Hospital | Oslo, Norway | Recruiting |
| Maria Sklodowska-Curie National Research Institute of Oncology | Warsaw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06057350